阿里健康近日完成对阿里巴巴集团旗下公司Ali JK所持离岸控股公司Ali JK ZNS Limited的100%股权的收购，礼德律师事务所代表卖方Ali JK参与交易。

根据礼德的一份新闻稿，该交易对价为80.75亿港元，阿里健康通过向卖方发行股份支付对价。

本项目的目标业务包括卖方在天猫、天猫超市及天猫国际平台销售药物、特殊医学用途配方食品、医疗器械、成人用品、保健用品、医疗及健康服务及蓝帽子保健食品的业务。此次收购是阿里健康持续发展其保健相关电商平台业务的重要一步。

礼德团队项目牵头律师为香港办事处合伙人杨能妮。

Reed Smith on Alibaba Health’s acquisition of e-commerce business

Reed Smith has advised Ali JK Nutritional Products, a wholly-owned subsidiary of Alibaba Group, on the selling of its 100% equity interest in Ali JK ZNS to Alibaba Health Information Technology.

The transaction consideration was about $1 billion and was satisfied by Alibaba Health issuing consideration shares to Ali JK at completion.

According to Reed Smith, the target business comprises the selling of pharmaceutical products, medical purpose food products, medical devices, healthcare products, and medical and healthcare services on the e-commerce platforms of Tmall, Tmall Supermarket and Tmall Global. The acquisition represents an important step in Alibaba Health’s ongoing development of its healthcare related e-commerce platform business.

The Reed Smith team was led by Hong Kong partner Denise Jong.

To contact the editorial team, please email ALBEditor@thomsonreuters.com.